1 completed, 1 withdrawn. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
Follow Fna: new trials by email Literature Review of Fna trials Research Report on Fna
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma Fine-Needle Aspiration, Irinotecan, Irinotecan Hydrochloride - Metastatic Ewing Sarcoma, Recurrent Ewing Sarcoma | Phase 1 / Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2021-09-15 | 2022-02-10 | |
| Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma Decitabine, Temozolomide, biopsy - Malignant Melanoma | Phase 1 / Phase 2 | Completed | Hussein Tawbi | 39 | 2008-06-01 | 2017-10-03 |
Melanoma (1) · Neoplasm Metastasis (1) · Sarcoma, Ewing (1) · Skin Neoplasms (1)
Hussein Tawbi (1) · M.D. Anderson Cancer Center (1)
United States (2)
Hussein Tawbi, MD (1) · Robert S Benjamin (1)